Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

ASAHI KASEI CORP (3407)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/06/2012 | 04:35am CEST

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASAHI KASEI CORP
04/12ASAHI KASEI : "Hollow Fiber Membrane Blood Purifying Device" in Patent Applicati..
AQ
04/07ASAHI KASEI : $25,600 Federal Contract Awarded to Zoll Medical
AQ
03/28ASAHI KASEI CORP : Ex-dividend day for for final dividend
FA
03/22GLOBAL MEMBRANE TECHNOLOGIES FOOD AN : 99strategy.biz added a depth and professi..
AQ
03/08ASAHI KASEI : Results of Landmark Wearable Defibrillator Trial to Be Presented a..
AQ
03/08ASAHI KASEI : Fanshawe Faculty Awarded ZOLL Foundation Research Grant
AQ
02/18ASAHI KASEI : Stanford first Ky. fire department to use new CPR devices
AQ
02/08ASAHI KASEI : Joint development agreement for Japan’s first abdominal aort..
PU
02/08ASAHI KASEI : Home Order Trends – January 2018
PU
02/08ASAHI KASEI : Grady EMS to get new heart monitors
AQ
More news
News from SeekingAlpha
02/07Asahi Kasei Corp. ADR 2017 Q4 - Results - Earnings Call Slides 
2017Asahi Kasei Corp. ADR 2017 Q2 - Results - Earnings Call Slides 
2017Evotec collaborates with Japan's Asahi Kasei Pharma on drug discovery 
2016JAPANESE EQUITIES : False Dawn Or Rising Star? 
2016GMO International Active EAFE Strategy Q3 2016 Commentary 
Financials ( JPY)
Sales 2018 2 039 B
EBIT 2018 -
Net income 2018 165 B
Debt 2018 160 B
Yield 2018 2,02%
P/E ratio 2018 12,81
P/E ratio 2019 13,96
EV / Sales 2018 1,11x
EV / Sales 2019 1,03x
Capitalization 2 112 B
Chart ASAHI KASEI CORP
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 1 539  JPY
Spread / Average Target 2,2%
EPS Revisions
Managers
NameTitle
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Shuichi Sakamoto Director & Head-Corporate Finance
Hideyuki Yamagishi Senior Executive Officer, General Manager-R&D
Norio Ichino Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP1.28%19 622
SAUDI BASIC INDUSTRIES CORPORATION SJSC--.--%98 243
AIR LIQUIDE-0.33%55 127
PRAXAIR-2.59%43 266
SHIN-ETSU CHEMICAL CO LTD-10.41%42 828
LYONDELLBASELL INDUSTRIES-2.39%42 390